coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Fleetwood PCN, Wyre · Health Inequalities Profile

    PCN U74229 · NHS Lancashire and South Cumbria Integrated Care Board · 3 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    28,144

    Registered population

    57.0% aged 18–64

    23.5%

    Aged 65+

    ICB 20.0% · England 17.9%

    3.1%

    Ethnic minority (non-White)

    1.0% Asian · England 9.6%

    61.4%

    In IMD quintile 1

    ICB 30.6% · England 21.0%

    ~16,465

    Core20 residents (est.)

    Resident basis; registered basis ~17,281 · see page 3

    5,593

    Hypertension register

    +5.00% in 3 yrs · England +5.60%

    464

    SMI register

    37.7% of Wyre's

    1,014

    COPD register

    Reviews -11.34% in 3 yrs

    Forecast to 2030

    6,334

    Hypertension patients, 2030

    +741 on today

    64.3%

    QRISK ≥20% on statins, 2030

    -0.13pp over 3 yrs

    5.5%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    -11.3%
    COPD review rate fell over three years.

    COPD annual reviews fell 11.3% over 2023 to 2025 to 68.9% (England +2.8% to 76.4%), with The Mount View Practice at 61.0%.

    83.9%
    24-month vaccine uptake trails 95.0% target.

    In Q1 2025/26 (cohort 56), 24-month MMR1 is 83.9% (England 88.3%) and 6-in-1 is 85.7% (England 92.2%), both below the 95.0% target.

    73.3%
    Hypertension target control above England, though falling.

    Hypertension treated to target is 73.3% against 70.3% in England and the ICB, though it fell 4.5% over 2023 to 2025 (England +3.6%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Fleetwood PCN has 23.5% aged 65+, exceeding England and ICB but below Wyre

    Fleetwood PCN registers 28,144 patients across three practices. Patients aged 65+ account for 23.5% (6,614 patients), below Wyre (27.1%) but above the ICB (20.0%) and England (17.9%). Patients aged 0-17 comprise 19.5% (5,480), and aged 18-64 make up 57.0% (16,050). On a Census resident base rather than registered patients, 96.9% identify as White (Wyre 97.5%, ICB 87.8%, England 81.1%), with a 3.1% ethnic minority share. Primary care list size is projected to grow 2.7% to 2030 under an unverified projection method.

    Age profile

    0–1719.5%
    18–6457.0%
    65+23.5%

    65+: ICB 20.0%, England 17.9%

    Ethnicity

    White96.9%
    Mixed1.3%
    Asian1.0%
    Other0.5%
    Black0.3%

    Older people · falls rows are Wyre local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Wyre LA)1,5062,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)85.5%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)56.9%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Wyre LA)8141,0219552024/25
    Falls deaths, all ages, per 100,000 (Wyre LA)11.518.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    At 61.4%, Core20 deprivation markedly exceeds Wyre and England across all member practices

    Fleetwood PCN's Core20 share is 61.4%, well above Wyre (15.0%), the ICB (30.6%) and England (21.0%), with an average IMD decile of 3.0 (England 5.5). Across practices, Core20 concentration spans 13.4 pp: The Mount View Practice has 67.6% (8,450 estimated patients), Fleetwood Surgery has 59.8% (3,659), and Broadway Medical Centre has 54.3% (5,172). Resident estimates identify 16,465 Core20 individuals, though practice registered estimates sum to 17,281. The distribution combines high practice share at The Mount View Practice with high registered patient volume at Broadway Medical Centre.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Mount View67.6% · 8,450 patients
    Fleetwood59.8% · 3,659 patients
    Broadway54.3% · 5,172 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    464

    SMI register

    1.62% recorded prevalence

    157

    Learning disability register

    0.55% recorded prevalence

    10

    Care homes, 347 beds

    In the PCN catchment

    10.6%

    Provide unpaid care

    Wyre, Census 2021

    The PCN registers 464 patients with severe mental illness (1.6% vs Wyre 1.1%, ICB 1.2%, England 1.0%) and 157 with learning disabilities (0.6% vs Wyre 0.5%, ICB 0.6%, England 0.6%). Catchment services include 10 care homes with 347 beds, although resident registration is unconfirmed.

    Severe mental illness: physical health checks

    SMI prevalence is 1.6% (England 1.0%). While 80.8% had a blood pressure check (England 83.4%), only 72.8% had a recorded BMI (England 82.1%), dropping to 65.0% at The Mount View Practice, showing uneven metabolic monitoring across practices.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    5,593

    Hypertension register

    +5.00%

    Register growth, 3 yrs

    Wyre +7.69% · England +5.60%

    −3.62pp

    BP control, under 80

    ≤140/90 · −3.59pp aged 80+

    +741

    More patients by 2030

    Forecast 6,334 (21.57%)

    Hypertension case-finding and control

    Fleetwood PCN records 5,593 patients on its hypertension register, a 19.6% prevalence trailing Wyre (21.7%) but exceeding the ICB (17.2%) and England (15.2%). Blood pressure control under 80 is 70.4% (Wyre 70.1%; England 67.8%), ranging from 64.4% at Broadway Medical Centre to 79.7% at Fleetwood Surgery. However, control under 80 fell 4.9% over 2023 to 2025 (England +3.2%), and hypertension treated to target fell 4.5% to 73.3% (England +3.6%). Falling three-year blood pressure control despite high recorded prevalence means the PCN should prioritise systematic recall and therapy reviews to reverse eroding control thresholds.

    Lipids and statins

    Patients with QRISK ≥ 20% on lipid-lowering therapy reach 64.6% (England 63.6%), but fell 0.2% over 2023 to 2025 (England +6.2%). Statin treatment for diabetes without cardiovascular disease trails England at 69.6% (England 73.2%), falling 6.1% (England +2.1%). Trailing statin uptake in diabetes requires prioritising recall of eligible diabetic patients for primary prevention.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202670,410£1.20£1.64£1.86£84,492
    Cardiovascular (all), 2025106,995£3.40£3.38£3.33£363,783

    For lipid-regulating drugs in 2026, the PCN prescribed 70,410 items at £1.20 per item (Wyre £1.45; ICB £1.64; England £1.86), spending £84,492 (£46,471 less than at England's unit cost), though unit cost does not indicate clinical efficiency. Lower unit costs than England mean the PCN can prioritise reviewing undertreated high-risk patients without excessive expenditure pressure.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −2.90%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −2.29%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 3.5% (1,014 patients; England 1.9%), but COPD annual reviews fell 11.3% over three years to 68.9% (England +2.8% 3-year change; England 76.4%), dropping to 61.0% at The Mount View Practice. Asthma prevalence is 8.0% (2,165 patients), and asthma reviews fell 2.9% over three years to 68.4% (England +4.4% 3-year change; England 65.7%). Prescribing of asthma management items for ages 5 to 19 is 2,658 per 1000 (England 1,488).

    Cancer register and children's immunisation

    Cancer prevalence is 4.5% (1,275 patients; England 3.8%). In childhood immunisations, 24-month uptake lags behind the 95.0% target: MMR dose 1 is 83.9% (below target by 11.1 pp; England 88.3%) and 6-in-1 complete primary course is 85.7% (below target by 9.3 pp; England 92.2%). By contrast, age-5 MMR2 coverage reaches 94.8% (England 82.8%).

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months93.3%

    England 91.0%

    6-in-1 complete primary course at 24 months85.7%

    England 92.2%

    MMR dose 1 at 24 months83.9%

    England 88.3%

    MMR dose 2 at age 594.8%

    England 82.8%

    4-in-1 pre-school booster at age 594.8%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    52.4%

    Lancashire and South Cumbria ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,010

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Lancashire and South Cumbria ICBEnglandNo usable stageStaged cancers
    Breast86.0%85.4%6%1,561
    Prostate42.4%53.2%11%1,404
    Lung31.1%33.8%15%1,374
    Bowel44.2%47.0%13%1,198
    Skin cancer86.1%87.8%21%519

    In 2022 across NHS Lancashire and South Cumbria ICB, 52.4% of staged cancers were diagnosed at stage 1 or 2, down 1.2 pp since 2013 and trailing England (55.3%), needing about 2,010 extra early-stage cases to reach 75.0%. In Fleetwood PCN, cervical screening coverage aged 25-49 is 63.7% (England 66.8%; Wyre 73.0%), with a -3.4% three-year change over 2023 to 2025 (England -1.0%). Breast screening coverage is 60.5% (England 69.9%; Wyre 73.4%), with a +21.0% change over 2023 to 2024 (England +8.4%). System stage data describes the ICB, not PCN performance. Lower PCN screening coverage may slow early case identification, indicating a need for systematic recall.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, Blackpool Teaching Hospitals NHS Foundation Trust achieved 67.5% on the cancer 62-day standard, below the ICB (73.6%) and England (71.2%). For the 28-day faster diagnosis standard, the trust achieved 71.4% (ICB 78.4%; England 79.3%), while meeting the 31-day standard at 98.0% (ICB 93.6%; England 92.5%). Across all diagnostic tests, 26.5% of patients waited 6+ weeks at the trust (England sum of providers 23.1%). These acute figures reflect provider performance rather than PCN-specific cohorts. Provider diagnostic and treatment waits could extend patient pathways following cancer referrals from primary care.

    Pathways within standard (%)Blackpoolof Morecambe BayLancashireLancashire and South Cumbria ICBEngland
    28-day faster diagnosis (75%)71.3878.3982.9078.3979.32
    31-day treatment (96%)97.9695.2289.4393.6292.50
    62-day referral to treatment (85%)67.4872.3575.0473.6271.16
    Diagnostic waits over 6 weeks (%)Blackpoolof Morecambe BayLancashireEngland
    MRI21.804.042.4121.40
    CT16.4913.7614.979.92
    Echocardiography7.5710.5513.8528.48
    Colonoscopy13.080.600.0030.83
    Gastroscopy12.471.450.0029.02
    All 15 DM01 tests26.5410.4426.6523.14
    Community services activityLancashire residentsLancashire and South Cumbria ICB
    Care contacts126,445193,720
    Referrals20,41529,855
    Patients with a contact47,32065,335

    Community services (residents of Lancashire), Jun 2026 (provisional). In June 2026, provisional community services activity recorded 293,090 care activities for Lancashire residents, within 533,345 activities across NHS Lancashire and South Cumbria Integrated Care Board. Contacts with adults aged 65+ accounted for 56.9% of borough residents' contacts. These counts reflect submitting provider activity and are not unique PCN patients.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice phone contact ease varies by 29.3 percentage points across the PCN

    Across 2025/26, overall QOF achievement exceeds England (92.5%) at Fleetwood Surgery (95.9%), The Mount View Practice (95.2%), and Broadway Medical Centre (94.7%). Vaccination achievement shows a 29.1 pp spread, from 53.1% at Broadway Medical Centre to 82.2% at The Mount View Practice. Personalised care adjustment rates range from 7.2% at Fleetwood Surgery to 13.1% at The Mount View Practice.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Mount View11367.662.4%62.0%86.7%
    Fleetwood Surgery10359.884.7%56.6%76.8%
    Broadway11054.355.4%66.6%66.6%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNWyreAssetPCNWyre
    Care homes (catchment)10 (347 beds)n/aSchools (catchment)17n/a
    Children's centres27Places of worship1283
    Libraries16Food banks (VCS)n/a1
    Day centres (VCS)n/a3Carers support groups (VCS)n/a2
    Primary schools (LA maintained)531Primary academies26
    Special schoolsn/a1

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    COPD annual review recall recovery

    COPD review coverage is 68.9% across a COPD register of 1,014 patients (3.5% prevalence vs England 1.9%), compared with England (76.4%), Wyre (75.1%) and the ICB (76.9%), with a three-year change of -11.3% over 2023 to 2025 (England +2.8%). Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Option 2

    Hypertension case-finding and titration review

    Hypertension prevalence is 19.6% (5,593 patients; England 15.2%; Wyre 21.7%), a modelled gap of -1,307 to +508 patients on 28,144 list size. Control to target is 73.3% but fell 4.5% over 2023 to 2025 (England +3.6%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 3

    Structured asthma annual review recall

    Asthma review coverage is 68.4% across 2,165 register patients (8.0% prevalence; England 65.7%; Wyre 68.7%), leaving 684 (rounded: about 680) without a recorded review after a 2.9% three-year fall over 2023 to 2025 (England +4.4%). Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older adult proactive care coordination (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 outreach and support (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health checks (p4)SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension recall and titration review (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Early childhood immunisation catch-up (p6)MMR dose 1 coverage at 24 months10YHP sickness to prevention · 95% targetPCN
    Screening recall and uptake review (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice access and triage review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · COPD annual review recall recovery (p12)COPD register · COPD: QOF prevalence · COPD patients with a review in the last 12 monthsCore20PLUS5 approach · Tobacco and Vapes BillPCN & Practice
    Option 2 · Hypertension case-finding and titration review (p12)Hypertension register · Hypertension: QOF prevalence · Registered populationCore20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Option 3 · Structured asthma annual review recall (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15